Select Your Region
Globale
A study to investigate the effectiveness of trastuzumab emtansine compared with trastuzumab in a type of breast cancer (called HER2 positive breast cancer) for patients who still have signs of tumours after receiving previous treatment and undergoing surgery (KATHERINE)
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)
Tumori Tumore al seno Tumore al seno Her-2 positivo Tumore al seno HER2-positivo
Per la versione più aggiornata di queste informazioni per favore vai su www.peripazienti.roche.it